Project Details
Description
MT2024-33 A Phase 1/2a Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001)...
| Status | Active |
|---|---|
| Effective start/end date | 9/25/24 → 9/24/35 |
Funding
- BLUESPHERE BIO, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.